Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D Verrico

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
The International Journal of Neuropsychopharmacology|May 22, 2016
Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory StudyChristopher D Verrico, Colin N Haile, Richard De La Garza, et al.
The International Journal of Neuropsychopharmacology|September 14, 2015
Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use DisorderRichard De La Garza, Christopher D Verrico, Thomas F Newton, et al.
The American Journal on Addictions|August 21, 2018
FAAH variant Pro129Thr modulates subjective effects produced by cocaine administrationMarguerite M Patel, David A Nielsen, Thomas R Kosten, et al.
Journal of Psychopharmacology (Oxford, England)|November 27, 2014
A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disordersJames J Mahoney, Daisy G Y Thompson-Lake, Kimberly Cooper, et al.
Expert Opinion on Investigational Drugs|September 17, 2013
Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medicationsChristopher D Verrico, Colin N Haile, Thomas F Newton, et al.
Psychiatry Research|June 22, 2014
The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disordersJames J Mahoney, Richard De La Garza, Brian J Jackson, et al.
Scientific Reports|May 11, 2021
A randomized trial of safety and pharmacodynamic interactions between a selective glucocorticoid receptor antagonist, PT150, and ethanol in healthy volunteersClaire Morice, Dewleen G Baker, Marguerite M Patel, et al.
Frontiers in Psychiatry|August 9, 2021
Cortical Correlates of Impulsive Aggressive Behavior in Pediatric Bipolar DisorderAlessio Simonetti, Sherin Kurian, Johanna Saxena, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 15, 2005
Primate trace amine receptor 1 modulation by the dopamine transporterGregory M Miller, Christopher D Verrico, Amy Jassen, et al.
Psychiatry Research|August 5, 2015
Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humansThomas F Newton, Colin N Haile, James J Mahoney, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
The International Journal of Neuropsychopharmacology|May 22, 2016
Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory StudyChristopher D Verrico, Colin N Haile, Richard De La Garza, et al.
The International Journal of Neuropsychopharmacology|September 14, 2015
Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use DisorderRichard De La Garza, Christopher D Verrico, Thomas F Newton, et al.
The American Journal on Addictions|August 21, 2018
FAAH variant Pro129Thr modulates subjective effects produced by cocaine administrationMarguerite M Patel, David A Nielsen, Thomas R Kosten, et al.
Journal of Psychopharmacology (Oxford, England)|November 27, 2014
A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disordersJames J Mahoney, Daisy G Y Thompson-Lake, Kimberly Cooper, et al.
Expert Opinion on Investigational Drugs|September 17, 2013
Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medicationsChristopher D Verrico, Colin N Haile, Thomas F Newton, et al.
Psychiatry Research|June 22, 2014
The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disordersJames J Mahoney, Richard De La Garza, Brian J Jackson, et al.
Scientific Reports|May 11, 2021
A randomized trial of safety and pharmacodynamic interactions between a selective glucocorticoid receptor antagonist, PT150, and ethanol in healthy volunteersClaire Morice, Dewleen G Baker, Marguerite M Patel, et al.
Frontiers in Psychiatry|August 9, 2021
Cortical Correlates of Impulsive Aggressive Behavior in Pediatric Bipolar DisorderAlessio Simonetti, Sherin Kurian, Johanna Saxena, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 15, 2005
Primate trace amine receptor 1 modulation by the dopamine transporterGregory M Miller, Christopher D Verrico, Amy Jassen, et al.
Psychiatry Research|August 5, 2015
Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humansThomas F Newton, Colin N Haile, James J Mahoney, et al.
Pageof 5